Myristoleic Acid (Synonyms: cis-9-Tetradecenoate, Oleomyristic Acid) |
| Katalog-Nr.GC11087 |
MyristoleinsÄure, eine zytotoxische Komponente im Extrakt aus Serenoa repens, induziert Apoptose und Nekrose in menschlichen LNCaP-Zellen der Prostata.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 544-64-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Myristoleic acid is a monounsaturated fatty acid found in the fruit extract of S. repens and in dairy extracts. It induces apoptosis and necrosis in human prostate cancer LNCaP cells at a rate of 8.8% and 8.1%, respectively. Myristoleic acid inhibits C. albicans germination in vitro with a minimal inhibitory concentration (MIC) of 9 µM. Furthermore, myristoleic acid inhibits osteogenesis in vitro via interference with cytoskeletal rearrangement and prevents RANKL-induced bone loss and osteoclast formation in mice.
Average Rating: 5 (Based on Reviews and 31 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *